Codes / ICD10CM / E11.3599

E11.3599 Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Type 2 Diabetes Mellitus with Proliferative Diabetic Retinopathy without Macular Edema, Unspecified Eye

Name of the Condition

  • Common Name: Type 2 Diabetes with Proliferative Diabetic Retinopathy (Unspecified Eye)
  • Medical Term: Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye

Summary

This condition is a severe complication of type 2 diabetes characterized by the growth of abnormal new blood vessels in the retina of an unspecified eye, without accompanying macular edema. It arises from prolonged high blood sugar levels damaging retinal blood vessels, potentially leading to vision impairment or blindness if untreated. The proliferative stage indicates advanced retinal damage requiring prompt management.

Causes

High blood sugar levels over time damage the small blood vessels in the retina, triggering the growth of fragile, abnormal blood vessels. This process is driven by diabetes-related vascular changes and metabolic imbalances, which disrupt normal retinal function and structure.

Risk Factors

  • Poorly controlled blood glucose levels.
  • Long duration of diabetes.
  • Hypertension and high cholesterol.
  • Smoking and obesity.
  • Family history of diabetic eye disease.

Symptoms

  • Often asymptomatic in early stages.
  • Blurred or distorted vision in the affected eye.
  • Floaters or dark spots in the visual field.
  • Sudden vision loss in severe cases.

Diagnosis

Diagnosis requires a comprehensive eye examination, including dilated retinal imaging (e.g., fundus photography or optical coherence tomography) to detect abnormal blood vessel growth. Fluorescein angiography may be used to assess retinal blood flow and confirm proliferative changes. Blood glucose and HbA1c testing are also performed to evaluate diabetes control.

Treatment Options

  • Laser photocoagulation to reduce abnormal blood vessel growth.
  • Anti-VEGF injections to inhibit vascular proliferation.
  • Vitrectomy surgery for advanced cases with severe bleeding or retinal detachment.
  • Intensive blood sugar control to slow disease progression.

Prognosis and Follow-Up

Prognosis depends on early detection and treatment. Regular eye examinations are critical to monitor for progression. With timely intervention, vision loss can be prevented or minimized, but untreated cases may lead to permanent blindness. Follow-up care includes ongoing diabetes management and periodic retinal assessments.

Complications

  • Permanent vision loss or blindness.
  • Retinal detachment.
  • Glaucoma.
  • Recurrent bleeding in the eye.

Lifestyle & Prevention

  • Maintain strict blood glucose control through diet, exercise, and medication.
  • Manage blood pressure and cholesterol levels.
  • Avoid smoking and limit alcohol intake.
  • Schedule regular eye exams, especially for those with long-standing diabetes.

When to Seek Professional Help

Seek immediate medical attention for sudden vision changes, floaters, or eye pain, as these may indicate severe complications. Routine eye evaluations are recommended annually for individuals with diabetes to detect early signs of retinopathy.

Tips for Medical Coders

Document the eye laterality as "unspecified" when the specific eye is not identified in the clinical record. Ensure supporting documentation confirms proliferative diabetic retinopathy without macular edema to justify the code. Include details on diabetes management and any ocular interventions performed.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

E11.3599 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.